Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.
Giant cell (GCA) and Takayasu's arteritis (TAK) are 2 forms of large-vessel vasculitis (LVV) that involve the aorta and its major branches. GCA has a predilection for the cranial branches, while TAK tends to affect the extracranial branches. Both disorders may also cause nonspecific constitutio...
Huvudupphovsmän: | Direskeneli, H, Aydin, S, Kermani, T, Matteson, E, Boers, M, Herlyn, K, Luqmani, R, Neogi, T, Seo, P, Suppiah, R, Tomasson, G, Merkel, P |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2011
|
Liknande verk
Liknande verk
-
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
av: Merkel, P, et al.
Publicerad: (2011) -
Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
av: Merkel, P, et al.
Publicerad: (2009) -
Current status of outcome measure development in vasculitis.
av: Merkel, P, et al.
Publicerad: (2014) -
DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
av: Luqmani, R
Publicerad: (2011) -
Systemic vasculitis--is it time to reclassify?
av: Watts, R, et al.
Publicerad: (2011)